Cite

Changes of markers of carotid atherosclerosis in subjects with type 2 diabetes mellitus between first the examination and the examination at the end of the study with regard to the rs4646994 (angiotensin-converting-enzyme insertion/deletion) and rs4341 polymorphisms.

rs4646994 ACE I/DIIIDDDp Value
Annual increase in CIMT (µm/year)14.28 (5.35-26.83)22.43 (16.73-32.19)20.34 (10.53-33.65)0.34
∆ Number of segments with plaques3.0 (1.0-3.0)1.0 (0.5-2.5)2.0 (1.0-3.0)0.42
∆ Sum of carotid plaques thickness (mm)4.00 (2.30-5.30)4.68 (3.30-7.60)6.22 (3.90-8.10)0.04

Multiple linear regression analysis for association of rs4646994 (angiotensin-converting-enzyme insertion/deletion) with carotid atherosclerosis progression in patients with type 2 diabetes mellitus.

Parameters∆ CIMT/Year∆ Number of Segments∆ Sum of Plaque Thickness
βp Valueβp Valueβp Value
A) rs4646994
Hypertension (yes/no)0.1440.590.2060.880.2720.53
Systolic blood pressure0.0310.420.0270.150.0140.69
ID0.1410.490.1160.510.8450.26
DD0.1020.630.1460.410.9520.04

Baseline characteristics of subjects with type 2 diabetes mellitus and control subjects without type 2 diabetes mellitus.

ParametersT2DM Subjects (n = 595)Control Subjects (n = 200)p Value
Age (years)61.38 ± 9.6560.07 ± 9.180.07
Gender: males females338 (56.8%) 257 (43.2%)92 (46.0%) 108 (54.0%)0.008
Duration of T2DM (years)11.25 ± 7.88
Cigarette smokers (%)53 (8.9%)34 (17.0%)0.002
Waist circumference (cm)108.65 ± 12.8893.31 ± 13.18<0.001
BMI (kg/m2)30.96 ± 4.7427.90 ± 4.420.16
SBP (mmHg)146.98 ± 19.98143.30 ± 16.60.86
DBP (mmHg)85.75 ± 11.6284.70 ± 11.60.19
Fasting glucose (mmol/L)8.04 ± 2.575.27 ± 0.87<0.001
Hb A1c (%)7.89 ± 3.564.79 ± 0.29<0.001
Total cholesterol (mmol/L)4.70 ± 1.195.36 ± 1.08<0.001
HDL cholesterol (mmol/L)1.19 ± 0.351.43 ± 0.37<0.001
LDL cholesterol (mmol/L)2.63 ± 0.943.24 ± 0.98<0.001
Triglycerides (mmol/L)1.9 (1.2-2.7)1.3 (0.9-1.9)<0.001
hs-CRP (mg/L)2.2 (1.0-4.3)1.3 (0.8-2.7)<0.001
CIMT (µm)1013.0 ± 208.0979.0 ± 141.00.03

Comparison of markers of carotid atherosclerosis in subjects with type 2 diabetes mellitus at the beginning and the end of the study with regard to the rs4646994 (angiotensin-converting-enzyme insertion/deletion) and rs4341 polymorphisms.

rs4646994 (ACE I/D)EnrollmentEndpoint
IIIDDDp ValueIIIDDDp Value
Intima media thickness (µm)998.0±147.01002.0±178.01012.0±178.00.621048.0±147.01054.0±128.01060.0±164.00.59
Involved segments (n)2.65±1.493.04±1.712.66±1.440.124.48±1.754.62±1.684.71±1.760.68
Sum of plaque thickness (mm)7.92±3.478.99±3.387.67±3.140.0910.17±4.2910.08±5.2611.38±5.320.76
eISSN:
1311-0160
Idioma:
Inglés
Calendario de la edición:
2 veces al año
Temas de la revista:
Medicine, Basic Medical Science, other